Why these 4 ASX shares are ending the week in the red

The Fortescue Metals Group Limited (ASX:FMG) share price is one of four ending the week in the red. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has just managed to break into positive territory and is up slightly at 6,215.9 points.

Four shares that have failed to follow the market higher today are listed below. Here's why they are ending the week in the red:

The Fortescue Metals Group Limited (ASX: FMG) share price has fallen 2.5% to $4.38. The iron ore producer has come under pressure this week after low grade iron ore prices tumbled lower. According to Metal Bulletin, the 58% Fe Premium Index was down almost 1% to US$52.02 per tonne overnight. Once again, there appears to be more of an appetite for high grade ore than the low grade ore Fortescue mines.

The Jatenergy Ltd (ASX: JAT) share price has plunged 21% lower to 6 cents after dairy manufacturer Nutritional Choice Australia (NCA) was placed into receivership. NCA manufactures dairy products for sale in China and has an agreement with Jatenergy for its Golden Koala infant formula brand. Management insists that NCA is solvent and this is the result of an internal dispute. It expects NCA to meet its obligations under the manufacturing agreement in full and on time. Clearly some shareholders aren't convinced. Keep away from this one would be my advice.

The Orocobre Limited (ASX: ORE) share price is down almost 2.5% to $5.18. This morning a broker note out of Morgan Stanley revealed that its analysts have retained their underweight rating and lowly $4.25 price target on the lithium miner's shares. Morgan Stanley is known to be a lithium bear and has predicted sharp price declines in the future.

The Starpharma Holdings Limited (ASX: SPL) share price has given back some recent gains and is down 2.5% to $1.19. I suspect this decline is the result of profit taking after its shares rocketed higher on Wednesday. That gain was due to the company signing a major license agreement with Mundipharma for VivaGel.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »